Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (5584)	9/18/1998 9:05:00 AM
From: Anthony Wong	Respond to of 9523

09/18 07:32 British TV Viagra trial sparks criticism LONDON, Sept 18 (Reuters) - A British television show that asked three men to try the controversial anti-impotence pill Viagra on air triggered a wave of criticism on Friday. Three men, accompanied by their wives, on Thursday took the diamond-shaped pill while watched by some two million viewers of Independent Television's 'This Morning' programme. The couples then retired to a nearby hotel. However, 90 minutes later just one couple reported successful lovemaking. Britain's Impotence Association condemned the TV programme for trivialising the widespread problem of male impotence. "I feel people with a serious condition should have more consultation than just giving them a Viagra tablet and sending them to a hotel room," Ann Craig of the Association was quoted in The Express newspaper as saying. "It makes the whole issue seem like fun when it certainly isn't," she added. Britain's television watchdog, the Independent Television Commission (ITC), said it had received seven complaints from the public about the TV show. "Most people said they thought it was inappropriate for daytime viewing and distasteful," an ITC spokeswoman said. The programme makers however defended the on-air experiment as an attempt to investigate the "hype" surrounding Viagra, which has been dubbed the "love drug" by the British press. It is made by U.S. drugs company Pfizer <PFE.N>.